Dudediligence.

Puma Biotechnology, Inc

PBYINASDAQ · Pharmaceutical Preparations
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$2,118,786

17 notices · 283,446 sh

Oct 2025 to Oct 2026

Reported ·

$991,800

12 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

11 of 12 reported sales carry the 10b5-1 box. Together they are 0.30% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-09-14: Cesano Alessandra, Form 1442026-09-14: WILSON TROY EDWARD, Form 1442026-07-06: AUERBACH ALAN H, Form 1442026-07-06: HUNT DOUGLAS M, Form 1442026-07-06: NOUGUES MAXIMO F, Form 1442026-06-12: Senderowicz Adrian, Form 1442026-06-12: MOYES JAY M, Form 1442026-06-12: Dorval Allison, Form 1442026-06-12: Stuglik Brian M, Form 1442026-06-12: WILSON TROY EDWARD, Form 1442026-01-07: AUERBACH ALAN H, Form 1442026-01-07: HUNT DOUGLAS M, Form 1442026-01-07: NOUGUES MAXIMO F, Form 1442026-01-06: NOUGUES MAXIMO F, Form 1442026-01-06: HUNT DOUGLAS M, Form 1442026-01-06: AUERBACH ALAN H, Form 1442025-11-11: MILLER MICHAEL PATRICK, Form 1442025-11-11: MILLER MICHAEL PATRICK, sold2026-01-06: NOUGUES MAXIMO F, sold2026-01-06: HUNT DOUGLAS M, sold2026-01-06: AUERBACH ALAN H, sold2026-06-12: Dorval Allison, sold2026-06-12: MOYES JAY M, sold2026-06-12: Senderowicz Adrian, sold2026-06-12: Stuglik Brian M, sold2026-06-12: WILSON TROY EDWARD, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-09-14Cesano Alessandra, Director$565,565
62,150 shplan 2026-06-15Form 4s on file end Jun 23144 ↗
2026-09-14WILSON TROY EDWARD, Director$45,500
5,000 shplan 2026-06-15Form 4s on file end Jun 23144 ↗
2026-07-06AUERBACH ALAN H, President and CEO$364,042
44,058 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-06HUNT DOUGLAS M, See Remarks$69,903
8,460 shno plan dateForm 4s on file end Jun 23144 ↗
2026-07-06NOUGUES MAXIMO F, Chief Financial Officer$77,555
9,386 shno plan dateForm 4s on file end Jun 23144 ↗
2026-06-12Senderowicz Adrian, Director$196,020
27,000 shplan 2025-03-12144 ↗
Form 4, 2026-06-15: sold 27,000 at $7.20 Form 4 ↗
2026-06-12MOYES JAY M, Director$159,720
22,000 shplan 2025-03-12144 ↗
Form 4, 2026-06-15: sold 22,000 at $7.22 Form 4 ↗
2026-06-12Dorval Allison, Director$84,289
11,610 shplan 2025-03-12144 ↗
Form 4, 2026-06-15: sold 11,610 at $7.20 Form 4 ↗
2026-06-12Stuglik Brian M, Director$58,806
8,100 shplan 2025-03-12144 ↗
Form 4, 2026-06-15: sold 8,100 at $7.20 Form 4 ↗
2026-06-12WILSON TROY EDWARD, Director$78,408
10,800 shplan 2025-03-12144 ↗
Form 4, 2026-06-15: sold 10,800 at $7.20 Form 4 ↗
2026-01-07AUERBACH ALAN H, President and CEO$105,893
18,012 shno plan dateno Form 4 on file144 ↗
2026-01-07HUNT DOUGLAS M, See Remarks$29,477
5,014 shno plan dateno Form 4 on file144 ↗
2026-01-07NOUGUES MAXIMO F, Chief Financial Officer$37,655
6,405 shno plan dateno Form 4 on file144 ↗
2026-01-06NOUGUES MAXIMO F, Chief Financial Officer$26,530
4,540 sh10b5-1 plan144 ↗
Form 4, 2026-01-08: sold 10,945 at $5.86 Form 4 ↗
2026-01-06HUNT DOUGLAS M, See Remarks$23,217
3,973 sh10b5-1 plan144 ↗
Form 4, 2026-01-08: sold 8,987 at $5.86 Form 4 ↗
2026-01-06AUERBACH ALAN H, President and CEO$98,979
16,938 sh10b5-1 plan144 ↗
Form 4, 2026-01-08: sold 34,950 at $5.86 Form 4 ↗
2025-11-11MILLER MICHAEL PATRICK, Director$97,228
20,000 shno plan date144 ↗
Form 4, 2025-11-13: sold 20,000 at $4.86 Form 4 ↗